02.12.2024 20:29:58
|
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
This article Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos originally appeared on Benzinga.com.Weiter zum vollständigen Artikel bei Benzinga

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CGI Group Inc.mehr Nachrichten
Analysen zu CGI Group Inc.mehr Analysen
Aktien in diesem Artikel
Glaukos Corp | 92,50 | 3,35% |
|
Intuitive Surgical Inc | 457,45 | 0,87% |
|
Morgan Stanley | 105,68 | 2,86% |
|
Morgan Stanley Deposit Shs Repr 1-1000th Flt Rate Non Cum Pfd Shs Series - A- | 23,31 | -0,77% |
|
Morgan Stanley Deposit Shs Repr 1-1000th Non-Cum Pfd Shs Series -F- | 25,40 | 0,12% |
|
Morgan Stanley Deposit Shs Repr 1-1000th Non-Cum Pfd Shs Series -I- | 25,31 | 0,20% |
|
Morgan Stanley Deposit Shs Repr 1-1000th Non-Cum Pfd Shs Series -E- | 25,61 | 0,12% |
|
Morgan Stanley Deposit Shs Repr 1-1000th Non-Cum Pfd Registered Shs Series -K- | 24,60 | 0,00% |
|
Nevro Corp | 5,25 | 0,00% |
|
Stryker Corp. | 333,50 | -0,60% |
|